Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(11%)
Results Posted
43%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_4
3
33%
Ph phase_3
1
11%
Ph not_applicable
1
11%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 31 (16.7%)
Phase 43 (50.0%)
N/A1 (16.7%)

Trials by Status

completed778%
recruiting111%
terminated111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_1

Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

NCT07171203
completednot_applicable

Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique

NCT03847545
completedphase_4

A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS

NCT02208050
completedphase_4

Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.

NCT02849782
completed

An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice

NCT01480063
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07171203Phase 1

Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

Recruiting
NCT03847545Not Applicable

Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique

Completed
NCT02208050Phase 4

A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS

Completed
NCT02849782Phase 4

Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.

Completed
NCT01480063

An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice

Completed
NCT03164018

Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis

Completed
NCT02219932Phase 3

Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis

Completed
NCT01480076Phase 4

Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis

Completed
NCT01532154

Fampridine Pregnancy Exposure Registry

Terminated

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9